Meizhang Li

2.7k total citations · 1 hit paper
46 papers, 1.9k citations indexed

About

Meizhang Li is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Meizhang Li has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 24 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Meizhang Li's work include Chemokine receptors and signaling (11 papers), Cancer Cells and Metastasis (6 papers) and Extracellular vesicles in disease (6 papers). Meizhang Li is often cited by papers focused on Chemokine receptors and signaling (11 papers), Cancer Cells and Metastasis (6 papers) and Extracellular vesicles in disease (6 papers). Meizhang Li collaborates with scholars based in United States, China and Australia. Meizhang Li's co-authors include Justin D. Lathia, Richard M. Ransohoff, Jeremy N. Rich, Anita B. Hjelmeland, Laura Martínez‐Muñoz, Marcel Batten, Fabienne Mackay, Frédéric Sierro, Richard P. Harvey and Helen Leung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature Neuroscience.

In The Last Decade

Meizhang Li

44 papers receiving 1.8k citations

Hit Papers

Disrupted cardiac development but normal hematopoiesis in... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers

Meizhang Li
Deric M. Park United States
Jingxin Qiu United States
Ichiro Nakano United States
Meizhang Li
Citations per year, relative to Meizhang Li Meizhang Li (= 1×) peers Kirsten Hattermann

Countries citing papers authored by Meizhang Li

Since Specialization
Citations

This map shows the geographic impact of Meizhang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meizhang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meizhang Li more than expected).

Fields of papers citing papers by Meizhang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meizhang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meizhang Li. The network helps show where Meizhang Li may publish in the future.

Co-authorship network of co-authors of Meizhang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Meizhang Li. A scholar is included among the top collaborators of Meizhang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meizhang Li. Meizhang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Meizhang, Rupal P. Soder, Sunil Abhyankar, et al.. (2025). Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trials. Cytotherapy. 27(10). 1219–1228. 3 indexed citations
3.
Li, Meizhang, et al.. (2022). Use of miRNA Sequencing to Reveal Hub miRNAs and the Effect of miR-582-3p/SMAD2 in the Progression of Hepatocellular Carcinoma. Frontiers in Genetics. 13. 819553–819553. 5 indexed citations
4.
Huang, Cheng-Liang, Meizhang Li, Ben Liu, et al.. (2021). Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review. Frontiers in Oncology. 11. 642110–642110. 42 indexed citations
5.
Li, Meizhang, Gusheng Tang, Fei Yang, et al.. (2020). Suppression of Hematopoietic Primitive Cells in Patients with Secondary Failure of Platelet Recovery after Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 26(10). 1840–1854. 6 indexed citations
6.
Soder, Rupal P., Buddhadeb Dawn, Mark L. Weiss, et al.. (2020). A Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease. Stem Cell Reviews and Reports. 16(5). 979–991. 29 indexed citations
7.
Jiang, Zongmin, Bo Gao, Min Hu, et al.. (2018). Conserved structure and function of chemokine CXCL8 between Chinese tree shrews and humans. Gene. 677. 149–162. 2 indexed citations
8.
Gao, Bo, Zongmin Jiang, Zhongshan Yang, et al.. (2018). Upregulation of chemokine CXCL10 enhances chronic pulmonary inflammation in tree shrew collagen-induced arthritis. Scientific Reports. 8(1). 9993–9993. 24 indexed citations
9.
Jiang, Zongmin, Yonggang Li, Xinglai Ji, et al.. (2017). Protein profiling identified key chemokines that regulate the maintenance of human pluripotent stem cells. Scientific Reports. 7(1). 14510–14510. 12 indexed citations
10.
Bai, Li, Yangyang Hou, Ming Zhu, et al.. (2015). 3’-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway. The International Journal of Neuropsychopharmacology. 19(4). pyv112–pyv112. 25 indexed citations
11.
Wang, Wenxue, et al.. (2015). All-Trans Retinoic Acid-Induced Deficiency of the Wnt/β-Catenin Pathway Enhances Hepatic Carcinoma Stem Cell Differentiation. PLoS ONE. 10(11). e0143255–e0143255. 23 indexed citations
12.
Liu, Zhong‐Jian, Yang Sun, Shirui Tan, et al.. (2015). Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells. Tumor Biology. 37(5). 6661–6671. 28 indexed citations
13.
Wang, Wei, Lichao Zhang, Wenxue Wang, et al.. (2014). CXC Chemokine CXCL12 and Its Receptor CXCR4 in Tree Shrews (Tupaia belangeri): Structure, Expression and Function. PLoS ONE. 9(5). e98231–e98231. 15 indexed citations
14.
Dai, Jie, Shirui Tan, Zhong‐Jian Liu, et al.. (2014). MTERF1 regulates the oxidative phosphorylation activity and cell proliferation in HeLa cells. Acta Biochimica et Biophysica Sinica. 46(6). 512–521. 10 indexed citations
15.
Flavahan, William, Qiulian Wu, Masahiro Hitomi, et al.. (2013). Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nature Neuroscience. 16(10). 1373–1382. 377 indexed citations
16.
Hale, James S., Meizhang Li, Maksim Sinyuk, et al.. (2012). Context Dependent Role of the CD36 - Thrombospondin - Histidine-Rich Glycoprotein Axis in Tumor Angiogenesis and Growth. PLoS ONE. 7(7). e40033–e40033. 24 indexed citations
18.
Li, Meizhang & Richard M. Ransohoff. (2009). Chapter 4 Double‐Label Nonradioactive In Situ Hybridization for the Analysis of Chemokine Receptor Expression in the Central Nervous System. Methods in enzymology on CD-ROM/Methods in enzymology. 460. 91–103. 1 indexed citations
19.
Li, Meizhang & Richard M. Ransohoff. (2008). The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Seminars in Cancer Biology. 19(2). 111–115. 63 indexed citations
20.
Huang, DeRen, Michael Cossoy, Meizhang Li, et al.. (2007). Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus–negative patients. Annals of Neurology. 62(1). 34–39. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026